Literature DB >> 26221703

A Mixed-Effects Model with Time Reparametrization for Longitudinal Univariate Manifold-Valued Data.

J B Schiratti, S Allassonnière, A Routier, S Durrleman.   

Abstract

Mixed-effects models provide a rich theoretical framework for the analysis of longitudinal data. However, when used to analyze or predict the progression of a neurodegenerative disease such as Alzheimer's disease, these models usually do not take into account the fact that subjects may be at different stages of disease progression and the interpretation of the model may depend on some implicit reference time. In this paper, we propose a generative statistical model for longitudinal data, described in a univariate Riemannian manifold setting, which estimates an average disease progression model, subject-specific time shifts and acceleration factors. The time shifts account for variability in age at disease-onset time. The acceleration factors account for variability in speed of disease progression. For a given individual, the estimated time shift and acceleration factor define an affine reparametrization of the average disease progression model. This statistical model has been used to analyze neuropsychological assessments scores and cortical thickness measurements from the Alzheimer's Disease Neuroimaging Initiative database. The numerical results showed that we can distinguish between slow versus fast progressing and early versus late-onset individuals.

Entities:  

Mesh:

Year:  2015        PMID: 26221703     DOI: 10.1007/978-3-319-19992-4_44

Source DB:  PubMed          Journal:  Inf Process Med Imaging        ISSN: 1011-2499


  5 in total

1.  A multivariate nonlinear mixed effects model for longitudinal image analysis: Application to amyloid imaging.

Authors:  Murat Bilgel; Jerry L Prince; Dean F Wong; Susan M Resnick; Bruno M Jedynak
Journal:  Neuroimage       Date:  2016-04-16       Impact factor: 6.556

2.  Data-driven models of dominantly-inherited Alzheimer's disease progression.

Authors:  Neil P Oxtoby; Alexandra L Young; David M Cash; Tammie L S Benzinger; Anne M Fagan; John C Morris; Randall J Bateman; Nick C Fox; Jonathan M Schott; Daniel C Alexander
Journal:  Brain       Date:  2018-05-01       Impact factor: 13.501

3.  Predicting time to dementia using a quantitative template of disease progression.

Authors:  Murat Bilgel; Bruno M Jedynak
Journal:  Alzheimers Dement (Amst)       Date:  2019-02-28

4.  Bayesian latent time joint mixed-effects model of progression in the Alzheimer's Disease Neuroimaging Initiative.

Authors:  Dan Li; Samuel Iddi; Wesley K Thompson; Michael S Rafii; Paul S Aisen; Michael C Donohue
Journal:  Alzheimers Dement (Amst)       Date:  2018-08-29

5.  Characterizing heterogeneity in the progression of Alzheimer's disease using longitudinal clinical and neuroimaging biomarkers.

Authors:  Devendra Goyal; Donna Tjandra; Raymond Q Migrino; Bruno Giordani; Zeeshan Syed; Jenna Wiens
Journal:  Alzheimers Dement (Amst)       Date:  2018-08-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.